cp wire

CP Wire Articles

Sun Pharma Announce FDA Approval of Xelpros to Treat Open-angle Glaucoma or Ocular Hypertension
  • Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK)
  • BAK is associated with increased incidence of Ocular Surface Disease (OSD)... read more
Fri, 09/14/18 - 09:48 am
Alnylam Announces Encouraging Exploratory Cardiac Endpoint Data For Patisiran in hATTR Amyloidosis
  • In post-hoc analysis, the exposure-adjusted rates of all-cause death and/or hospitalization were reduced approximately 50% in patients receiving Patisiran vs placebo
  • hATTR... read more
Fri, 09/14/18 - 09:35 am
Allogene Therapeutics Announces Filing For IPO
  • Number of shares and price range yet to be determined
  • Allogene has seven products in pre-clinical development and 1 in Ph I trials

Allogene Therapeutics, Inc., a... read more

Fri, 09/14/18 - 09:21 am
FDA Pushes Back PDUFA Date of Acorda's Parkinson’s Drug
  • Inbrija PDUFA goal date extended from October 5, 2018 to January 5, 2019
  • Acorda shares down over 14% in pre-market trading

Acorda Therapeutics, Inc. (Nasdaq:ACOR)... read more

Thu, 09/13/18 - 09:26 am
M3 Biotechnology Begins Testing of Alzheimer’s Therapy in Adults with the Disease
  • NDX-1017 is intented to halt or reverse Alzheimer's
  • It a completely different mechanism of action than other drug candidates currently in development
  • NDX-1017 addresses... read more
Thu, 09/13/18 - 09:13 am

Pages